Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för radezolid. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

12 träffar

Bibliografisk träff 2024-03-13

Recent advances in the exploration of oxazolidinone scaffolds from compound development to antibacterial agents and other bioactivities.

Ampomah-Wireko M, Chen S, Li R, Gao C, Wang M, Qu Y, Kong H, Nininahazwe L, Zhang E.

Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2024.116326

Bibliografisk träff 2023-03-01

Oxazolidinone: A promising scaffold for the development of antibacterial drugs.

Yuan S, Shen DD, Bai YR, Zhang M, Zhou T, Sun C, Zhou L, Wang SQ, Liu HM.

Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2023.115239

Bibliografisk träff 2020-11-02

Design, synthesis and antibacterial evaluation of novel oxazolidinone derivatives nitrogen-containing fused heterocyclic moiety.

Jiang J, Hou Y, Duan M, Wang B, Wu Y, Ding X, Zhao Y.

Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2020.127660

Bibliografisk träff 2019-10-21

Design and synthesis of biaryloxazolidinone derivatives containing amide or acrylamide moiety as novel antibacterial agents against Gram-positive bacteria.

Xu S, Jiang J, Qi Y, Ding X, Wu Y, Lei H, Zhao Y.

Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2019.126747

Bibliografisk träff 2018-12-06

Design and synthesis of biaryloxazolidinone derivatives containing a rhodanine or thiohydantoin moiety as novel antibacterial agents against Gram-positive bacteria.

Wu Y, Ding X, Xu S, Yang Y, Zhang X, Wang C, Lei H, Zhao Y.

Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2018.12.012

Bibliografisk träff 2018-09-05

Synthesis and antibacterial activity evaluation of novel biaryloxazolidinone analogues containing a hydrazone moiety as promising antibacterial agents.

Wu Y, Ding X, Ding L, Zhang Y, Cui L, Sun L, Li W, Wang D, Zhao Y.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2018.09.004

Bibliografisk träff 2010-09-13

Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with co-occurring mutations in ribosomal protein L3.

Locke JB, Morales G, Hilgers M, G C K, Rahawi S, José Picazo J, Shaw KJ, Stein JL.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.00714-10

Bibliografisk träff 2010-04-12

Cellular pharmacodynamics of the novel biaryloxazolidinone radezolid: studies with infected phagocytic and nonphagocytic cells, using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila.

Lemaire S, Kosowska-Shick K, Appelbaum PC, Verween G, Tulkens PM, Van Bambeke F.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.01724-09

Bibliografisk träff 2010-04-12

Cellular pharmacokinetics of the novel biaryloxazolidinone radezolid in phagocytic cells: studies with macrophages and polymorphonuclear neutrophils.

Lemaire S, Tulkens PM, Van Bambeke F.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.01723-09

Bibliografisk träff 2008-10-07

Design at the atomic level: design of biaryloxazolidinones as potent orally active antibiotics.

Zhou J, Bhattacharjee A, Chen S, Chen Y, Duffy E, Farmer J, Goldberg J, Hanselmann R, Ippolito JA, Lou R, Orbin A, Oyelere A, Salvino J, Springer D, Tran J, Wang D, Wu Y, Johnson G.

Bioorg Med Chem Lett · journal article · DOI 10.1016/j.bmcl.2008.10.011

Bibliografisk träff 2008-07-28

R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.

Skripkin E, McConnell TS, DeVito J, Lawrence L, Ippolito JA, Duffy EM, Sutcliffe J, Franceschi F.

Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.01193-07

Bibliografisk träff 2008-03-03

In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.

Lawrence L, Danese P, DeVito J, Franceschi F, Sutcliffe J.

Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.01383-07